Items 21 to 30 of 118 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Vacuolin-1 | 351986-85-1 | sc-216045 | 10 mg | $265.00 | 29 | |
Vacuolin-1 is a selective inhibitor of vacuolar H+-ATPase, impacting cellular homeostasis and autophagy processes. By modulating intracellular pH and ion gradients, it influences vesicular trafficking and lysosomal function. This compound alters the dynamics of endosomal and lysosomal pathways, leading to changes in cellular signaling and metabolism. Its unique interaction with membrane-bound proteins provides insights into the regulation of neuronal cell survival and synaptic integrity. | ||||||
IGF-1R Inhibitor, PPP | 477-47-4 | sc-204008A sc-204008 sc-204008B | 1 mg 10 mg 100 mg | $138.00 $203.00 $895.00 | 63 | |
IGF-1R Inhibitor, PPP, is a potent modulator of insulin-like growth factor signaling pathways, specifically targeting the IGF-1 receptor. By disrupting receptor dimerization and downstream signaling cascades, it influences cellular growth and differentiation. This compound exhibits unique binding kinetics, altering the phosphorylation states of key proteins involved in neuroplasticity. Its selective action on IGF-1R provides a deeper understanding of neurodevelopmental processes and synaptic modulation. | ||||||
DL-threo-Dihydrosphingosine | 73938-69-9 | sc-201389 | 10 mg | $194.00 | 1 | |
DL-threo-Dihydrosphingosine plays a pivotal role in neurobiology by influencing sphingolipid metabolism and cellular signaling pathways. It acts as a precursor in the synthesis of bioactive sphingolipids, which are crucial for neuronal development and function. Its unique structure allows for specific interactions with membrane proteins, modulating their activity and impacting synaptic transmission. Additionally, it participates in the regulation of apoptosis and neuroinflammation, highlighting its significance in maintaining neural homeostasis. | ||||||
Tigecycline | 220620-09-7 | sc-394197 sc-394197A | 5 mg 25 mg | $190.00 $448.00 | 1 | |
Tigecycline exhibits unique interactions with ribosomal RNA, inhibiting protein synthesis by binding to the 30S subunit of bacterial ribosomes. This action disrupts the decoding process, leading to the misreading of mRNA and ultimately stalling bacterial growth. Its distinct mechanism of action allows for a broad spectrum of activity against various pathogens, highlighting its role in modulating microbial protein expression and influencing cellular responses in neurobiological contexts. | ||||||
PKI (5-24), PKA Inhibitor Inhibitor | 99534-03-9 | sc-201159 | 500 µg | $255.00 | 15 | |
PKI (5-24), a potent PKA inhibitor, plays a significant role in neurobiology by selectively disrupting protein kinase A signaling pathways. Its unique ability to bind to the regulatory subunit of PKA alters phosphorylation states of target proteins, influencing downstream signaling cascades. This modulation affects synaptic transmission and plasticity, while also impacting gene expression related to neuronal development. Additionally, PKI (5-24) exhibits rapid kinetics, allowing for precise temporal control in cellular signaling events. | ||||||
Ligustilide | 4431-01-0 | sc-489178 sc-489178A | 10 mg 100 mg | $300.00 $700.00 | ||
Ligustilide is a bioactive compound that exhibits intriguing neurobiological properties through its modulation of neurotransmitter systems. It interacts with various receptors, influencing calcium signaling and neuronal excitability. Its unique structural features facilitate binding to specific ion channels, thereby affecting synaptic plasticity. Furthermore, Ligustilide is involved in the regulation of oxidative stress responses, contributing to neuronal resilience and overall cellular health in the nervous system. | ||||||
TAPI-2 | 187034-31-7 | sc-205851 sc-205851A | 1 mg 5 mg | $286.00 $1019.00 | 15 | |
TAPI-2 is a selective inhibitor of matrix metalloproteinases, influencing neurobiological processes by modulating extracellular matrix dynamics. Its unique interaction with the enzyme's active site alters substrate accessibility, thereby affecting proteolytic activity. This inhibition can lead to changes in neuronal morphology and synaptic connectivity. TAPI-2's specificity for certain metalloproteinases allows for targeted manipulation of signaling pathways involved in neuroinflammation and neurodegeneration, highlighting its role in cellular communication. | ||||||
EX 527 | 49843-98-3 | sc-203044 | 5 mg | $87.00 | 32 | |
EX 527 is a potent inhibitor of sirtuin 1, a key regulator in neurobiological pathways. By selectively binding to the enzyme's active site, it disrupts deacetylation processes, influencing histone modifications and gene expression. This modulation can lead to alterations in neuronal plasticity and survival. The compound's unique ability to traverse cellular membranes enhances its efficacy in targeting specific signaling cascades, thereby impacting neurodevelopment and synaptic function. | ||||||
Nemadipine-A | 54280-71-6 | sc-202727 | 5 mg | $66.00 | 3 | |
Nemadipine-A is a selective calcium channel blocker that modulates neurotransmitter release by inhibiting voltage-gated calcium channels. Its unique interaction with these channels alters calcium influx, influencing synaptic transmission and neuronal excitability. This compound exhibits distinct kinetics, with a rapid onset of action and a prolonged duration of effect, allowing for nuanced regulation of neuronal signaling pathways. Its ability to selectively target specific channel subtypes contributes to its role in shaping neurobiological responses. | ||||||
L-NG-Nitroarginine Methyl Ester (L-NAME) | 51298-62-5 | sc-200333 sc-200333A sc-200333B | 1 g 5 g 25 g | $48.00 $107.00 $328.00 | 45 | |
L-NG-Nitroarginine Methyl Ester (L-NAME) acts as a potent inhibitor of nitric oxide synthase, disrupting the production of nitric oxide, a crucial signaling molecule in the nervous system. By selectively blocking this pathway, L-NAME influences neurotransmission and vascular responses in neural tissues. Its unique interaction with the enzyme alters reaction kinetics, leading to a decrease in cyclic GMP levels, which modulates various neurobiological processes, including synaptic plasticity and neuronal communication. | ||||||